Hemorrhoidal Disease
11
1
1
6
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 11 trials
100.0%
+13.5% vs benchmark
9%
1 trials in Phase 3/4
17%
1 of 6 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 6 completed trials
Clinical Trials (11)
Clinical Outcomes After Laser Hemorrhoidoplasty
Multicenter Prospective Real-world Observational Study to Evaluate the Effectiveness of Phlebotonics, as Conservative Therapy in a Cohort of Patients With Symptomatic Hemorrhoidal Disease (HD) of I, II or III Goligher Grade
A Clinical Study on Alleviating Hemorrhoids-related Symptoms of Pelvic Radiation Therapy
Minimally Invasive Open Excisional Hemorrhoidectomy Compared to Conventional Open Excisional Hemorrhoidectomy: a Clinical Trial
War-Drill Model Guided Treatment of Hemorrhoids With Nimsai Herbal (NAJ)
Recurrence Rate of Hemorrhoidal Disease at 10 Years and More After HAL Doppler or HAL-RAR Intervention
Upper Rectal Artery Embolization in the Treatment of Hemorrhoidal Disease
HAL-RAR Technique for Treating Hemorrhoids
Effect of Early Warm Water Sitz Bath on Urinary Retention After Hemorrhoidectomy
Feasibility of Superior Rectal Artery Embolization for the Treatment of Hemorrhoidal Disease
Efficacy and Safety Evaluation of the Imescard Compound Water Smartweed Ointment